Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression
- 1 May 2003
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 22 (5) , 533-541
- https://doi.org/10.1016/s1053-2498(02)00571-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Microemulsion cyclosporin inhibits vascular remodelling and attenuates associated changes in profibrotic gene expression in an experimental model of allograft vasculopathyBritish Journal of Surgery, 2002
- Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNABritish Journal of Surgery, 2002
- Rapamycin in transplantation: A review of the evidenceKidney International, 2001
- Etiology and pathophysiology of chronic transplant dysfunctionTransplant International, 2000
- Molecular changes in extracellular matrix turnover after renal ischaemia–reperfusion injuryBritish Journal of Surgery, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- THERAPEUTIC BLOOD LEVELS OF SIROLIMUS (RAPAMYCIN) IN THE ALLOGRAFTED RATTransplantation, 1996
- Adventitial Myofibroblasts Contribute to Neointimal Formation in Injured Porcine Coronary ArteriesCirculation, 1996
- RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURYTransplantation, 1993
- Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991